| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Key Account Executive-4 |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 06, 2025 |
| Sales Executive-BC |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Janv. 05, 2025 |
| (Sr.) Sales Executive-Solid Tumor |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Dec. 29, 2024 |
| Associate Sales Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Dec. 03, 2024 |
| Medical Science Liaison-Oncology-Breast Cancer |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
Nov. 14, 2024 |
| (Senior) Medical Advisor (Radioligand Therapy) |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
Okt. 09, 2024 |
| (Sr.) Sales Executive-OPH |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Jūn. 12, 2024 |